Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, Faculty of Sciences, VU University Amsterdam, The Netherlands.
Bioorg Med Chem. 2011 Oct 15;19(20):6107-19. doi: 10.1016/j.bmc.2011.08.028. Epub 2011 Aug 27.
Hierarchical in silico screening protocols against the agonist bound acetylcholine binding protein (AChBP) crystal structure were efficient in identifying novel chemotypes for AChBP and the human α7 receptor. Two hit structures were cocrystallized with AChBP revealing intermolecular cation-π interactions with loop C but lacking intermolecular hydrogen bonding. The compounds act as competitive α7 receptor antagonists and as non-competitive α4β2 receptor inhibitors. These results underline the usability of AChBP in structure-based in silico screening strategies in finding novel scaffolds for the α7 receptor, but also illustrates some limitations of using AChBP as bait to find competitive α4β2 receptor ligands and α7 receptor agonists.
针对激动剂结合乙酰胆碱结合蛋白(AChBP)晶体结构的层次化计算机筛选方案,在鉴定新型 AChBP 和人α7 受体化学型方面非常有效。两种命中结构与 AChBP 共结晶,显示出与环 C 的分子间阳离子-π 相互作用,但缺乏分子间氢键。这些化合物作为竞争性α7 受体拮抗剂和非竞争性α4β2 受体抑制剂。这些结果强调了 AChBP 在基于结构的计算机筛选策略中寻找新型α7 受体支架的可用性,但也说明了使用 AChBP 作为诱饵寻找竞争性α4β2 受体配体和α7 受体激动剂的一些局限性。